Preoperative platelet to lymphocyte ratio is a valuable prognostic biomarker in patients with colorectal cancer
Main Authors: | You, Jie, Zhu, Gui-Qi, Xie, Linka, Liu, Wen-Yue, Shi, Liang, Wang, Ou-Chen, Huang, Zong-Hai, Braddock, Martin, Guo, Gui-Long, Zheng, Ming-Hua |
---|---|
Format: | Online |
Language: | English |
Published: |
Impact Journals LLC
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041922/ |
Similar Items
-
Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma
by: Que, Yi, et al.
Published: (2015) -
Comparison of preoperative neutrophil–lymphocyte, lymphocyte–monocyte, and platelet–lymphocyte ratios in patients with upper urinary tract urothelial carcinoma undergoing radical nephroureterectomy
by: Song, Xin, et al.
Published: (2016) -
Preoperative neutrophil:lymphocyte and platelet:lymphocyte ratios predict endometrial cancer survival
by: Cummings, M, et al.
Published: (2015) -
Platelet‐to‐lymphocyte ratio could be a promising prognostic biomarker for survival of colorectal cancer: a systematic review and meta‐analysis
by: Peng, Hong‐Xin, et al.
Published: (2016) -
Prognostic Significance of Retroperitoneal Lymphadenectomy, Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio in Primary Fallopian Tube Carcinoma: A Multicenter Study
by: Gungorduk, Kemal, et al.
Published: (2015)